Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204].

Renee Heffron, Sharon L Achilles, Laneta J Dorflinger, Janet P Hapgood, James Kiarie, Chelsea B Polis, Petrus S Steyn

Abstract readPublished Erratum

In one paragraph

Article in Contraception, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

Erratum for
Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.2019

5 · Who and what money

Authors and funding

7 authors.

Renee HeffronDepartment of Global Health, University of Washington, 325 Ninth Avenue Box, 359927, Seattle, WA, USA; Department of Epidemiology, University of Washington, 325 Ninth Avenue Box, 359927, Seattle, WA, USA. Electronic address: rheffron@uw.edu.

Sharon L AchillesDepartment of Obstetrics, Gynecology, and Reproductive Sciences and Center for Family Planning Research, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Magee-Womens Research Institute, Pittsburgh, PA, USA.

Laneta J DorflingerFHI 360, 359 Blackwell Street, Suite 200, Durham, NC, USA 27701.

Janet P HapgoodDepartment of Molecular and Cell Biology, Faculty of Science, University of Cape Town, Private Bag X3, Rondebosch, 7701, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Private Bag X3, Rondebosch, 7701, Cape Town, South Africa.

James KiarieDepartment of Reproductive Health and Research, World Health Organization (WHO), Geneva, Switzerland.

Chelsea B PolisGuttmacher Institute, 125 Maiden Lane, 7th Floor, Manhattan, New York, 10038, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 NorthWolfe St., Baltimore, MD 21205, USA.

Petrus S SteynDepartment of Reproductive Health and Research, World Health Organization (WHO), Geneva, Switzerland.

Funding

World Health Organization 001

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31229224

DOI10.1016/j.contraception.2019.05.014

PMCPMC6854462

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.